A 46-year-old woman with a 26-year history of pancolitis visited our hospital regularly. She had remained in remission for the past 5 years and was taking oral mesalamine. Annual endoscopy examination showed a slightly elevated reddish lesion (5mm) in the lower rectum (▶Fig. 1). Endocytoscopy (CF-H290ECI; Olympus, Tokyo, Japan) with narrow-band imaging revealed surface microvessels of uniform caliber and arrangement (▶Video 1). An artificial intelligence-based system (EndoBRAIN; Cybernet Systems, Tokyo, Japan) diagnosed the lesion as a neoplasm. On the basis of biopsy findings, we diagnosed the lesion as being high grade dysplasia (▶Fig. 2) and performed endoscopic submucosal dissection. After treatment, she was discharged on postoperative day 7, without any complications. The risk of developing colorectal cancer (CRC) is significantly elevated in patients with ulcerative colitis. Surveillance colonoscopy is usually performed to identify colitis-associated CRC. Endocytoscopy is a novel type of ultramagnification endoscopy that enables microscopic cellular observation, and evaluation of the endocytoscopic microvasculature has been used for the diagnosis of colorectal lesions [1]. The EndoBRAIN system accurately differentiates neoplastic from nonneoplastic lesions in endocytoscopic narrow-band images, when pathological findings are used as the standard [2]. However, its application in the diagnosis of colitis-associated CRC has not previously been reported. Our findings suggest that endocytoscopy can be used to obtain information regarding the endocytoscopic vascular pattern and that EndoBRAIN can help detect colitis-associated CRC. Furthermore, colitis-associated CRC is often difficult to diagnose because of the effects of inflammation and the use of EndoBRAIN can help nonexpert endoscopists to identify colitisassociated CRC, thereby helping to avoid unnecessary biopsies.
Paper
Full text
Is artificial intelligence a superior diagnostician in ulcerative colitis?
Semantic Scholar · Medicine · 2020
Abstract
A 46-year-old woman with a 26-year history of pancolitis visited our hospital regularly. She had remained in remission for the past 5 years and was taking oral mesalamine. Annual endoscopy examination showed a slightly elevated reddish lesion (5mm) in the lower rectum (▶Fig. 1). Endocytoscopy (CF-H290ECI; Olympus, Tokyo, Japan) with narrow-band imaging revealed surface microvessels of uniform caliber and arrangement (▶Video 1). An artificial intelligence-based system (EndoBRAIN; Cybernet Systems, Tokyo, Japan) diagnosed the lesion as a neoplasm. On the basis of biopsy findings, we diagnosed the lesion as being high grade dysplasia (▶Fig. 2) and performed endoscopic submucosal dissection. After treatment, she was discharged on postoperative day 7, without any complications. The risk of developing colorectal cancer (CRC) is significantly elevated in patients with ulcerative colitis. Surveillance colonoscopy is usually performed to identify colitis-associated CRC. Endocytoscopy is a novel type of ultramagnification endoscopy that enables microscopic cellular observation, and evaluation of the endocytoscopic microvasculature has been used for the diagnosis of colorectal lesions [1]. The EndoBRAIN system accurately differentiates neoplastic from nonneoplastic lesions in endocytoscopic narrow-band images, when pathological findings are used as the standard [2]. However, its application in the diagnosis of colitis-associated CRC has not previously been reported. Our findings suggest that endocytoscopy can be used to obtain information regarding the endocytoscopic vascular pattern and that EndoBRAIN can help detect colitis-associated CRC. Furthermore, colitis-associated CRC is often difficult to diagnose because of the effects of inflammation and the use of EndoBRAIN can help nonexpert endoscopists to identify colitisassociated CRC, thereby helping to avoid unnecessary biopsies.